BTK kinase occupies an important position in BCR signaling, and theoretically, due to the mimicry of BCR signaling by LMP2A, the combined use of BTKi may be effective in treating EBV‐associated B‐cell lymphoma [9]. The gene discussed is BCR; the disease is B-cell non-Hodgkin lymphoma.